Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-09-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.762928/full |
| _version_ | 1819073314719531008 |
|---|---|
| author | Ken-Hong Lim Ken-Hong Lim Shinobu Matsuura Bing Xu Bing Xu |
| author_facet | Ken-Hong Lim Ken-Hong Lim Shinobu Matsuura Bing Xu Bing Xu |
| author_sort | Ken-Hong Lim |
| collection | DOAJ |
| first_indexed | 2024-12-21T17:51:39Z |
| format | Article |
| id | doaj.art-3fbb1c25e7e548f5949ac4054e06c57f |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-21T17:51:39Z |
| publishDate | 2021-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-3fbb1c25e7e548f5949ac4054e06c57f2022-12-21T18:55:19ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-09-011110.3389/fonc.2021.762928762928Editorial: Novel Treatment Strategies for Myeloproliferative NeoplasmsKen-Hong Lim0Ken-Hong Lim1Shinobu Matsuura2Bing Xu3Bing Xu4Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei City, TaiwanDepartment of Medicine, MacKay Medical College, New Taipei City, TaiwanDepartment of Medicine–Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, United StatesDepartment of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, ChinaKey Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2021.762928/fullmyeloproliferative neoplasmschronic myeloid leukemiaCALRMPLtyrosine kinase inhibitor |
| spellingShingle | Ken-Hong Lim Ken-Hong Lim Shinobu Matsuura Bing Xu Bing Xu Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms Frontiers in Oncology myeloproliferative neoplasms chronic myeloid leukemia CALR MPL tyrosine kinase inhibitor |
| title | Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms |
| title_full | Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms |
| title_fullStr | Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms |
| title_full_unstemmed | Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms |
| title_short | Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms |
| title_sort | editorial novel treatment strategies for myeloproliferative neoplasms |
| topic | myeloproliferative neoplasms chronic myeloid leukemia CALR MPL tyrosine kinase inhibitor |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2021.762928/full |
| work_keys_str_mv | AT kenhonglim editorialnoveltreatmentstrategiesformyeloproliferativeneoplasms AT kenhonglim editorialnoveltreatmentstrategiesformyeloproliferativeneoplasms AT shinobumatsuura editorialnoveltreatmentstrategiesformyeloproliferativeneoplasms AT bingxu editorialnoveltreatmentstrategiesformyeloproliferativeneoplasms AT bingxu editorialnoveltreatmentstrategiesformyeloproliferativeneoplasms |